Market Closed -
Nyse
04:00:57 2024-05-31 pm EDT
|
5-day change
|
1st Jan Change
|
30.4
USD
|
+1.47%
|
|
+1.23%
|
-.--%
|
Fiscal Period: December |
2024
|
2025
|
2026
|
---|
Capitalization
1 |
4,633
|
-
|
-
|
Enterprise Value (EV)
1 |
4,724
|
4,504
|
4,225
|
P/E ratio
|
21.6
x
|
16.7
x
|
14.2
x
|
Yield
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.24
x
|
1.09
x
|
0.98
x
|
EV / Revenue
|
1.27
x
|
1.06
x
|
0.9
x
|
EV / EBITDA
|
13.3
x
|
10.1
x
|
8.16
x
|
EV / FCF
|
29.5
x
|
21.1
x
|
15.9
x
|
FCF Yield
|
3.39%
|
4.74%
|
6.27%
|
Price to Book
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
152,400
|
-
|
-
|
Reference price
2 |
30.40
|
30.40
|
30.40
|
Announcement Date
|
-
|
-
|
-
|
Fiscal Period: December |
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
3,730
|
4,257
|
4,706
|
EBITDA
1 |
-
|
355.7
|
448.2
|
518.1
|
EBIT
1 |
-
|
321.2
|
412.3
|
480.5
|
Operating Margin
|
-
|
8.61%
|
9.69%
|
10.21%
|
Earnings before Tax (EBT)
1 |
157.3
|
285.1
|
381.9
|
458.2
|
Net income
1 |
112.9
|
207.9
|
279
|
330.2
|
Net margin
|
-
|
5.57%
|
6.55%
|
7.02%
|
EPS
2 |
-
|
1.410
|
1.822
|
2.147
|
Free Cash Flow
1 |
-
|
160.4
|
213.3
|
265
|
FCF margin
|
-
|
4.3%
|
5.01%
|
5.63%
|
FCF Conversion (EBITDA)
|
-
|
45.09%
|
47.6%
|
51.16%
|
FCF Conversion (Net income)
|
-
|
77.14%
|
76.47%
|
80.27%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/13/24
|
-
|
-
|
-
|
Fiscal Period: December |
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
934.7
|
916.5
|
928.6
|
957.8
|
1,055
|
1,041
|
EBITDA
1 |
88.51
|
86.99
|
85.96
|
96.72
|
106.4
|
112.8
|
EBIT
1 |
79.96
|
77.62
|
77.63
|
85.96
|
99.92
|
101.5
|
Operating Margin
|
8.55%
|
8.47%
|
8.36%
|
8.98%
|
9.47%
|
9.75%
|
Earnings before Tax (EBT)
1 |
73.06
|
68.5
|
69.76
|
79.39
|
87.33
|
96.87
|
Net income
1 |
49.14
|
49.1
|
50.28
|
57.06
|
60.28
|
69.18
|
Net margin
|
5.26%
|
5.36%
|
5.41%
|
5.96%
|
5.71%
|
6.64%
|
EPS
2 |
0.3800
|
0.3250
|
0.3300
|
0.3750
|
0.4000
|
0.4550
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/13/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
91.3
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
129
|
408
|
Leverage (Debt/EBITDA)
|
-
|
0.2567
x
|
-
|
-
|
Free Cash Flow
1 |
-
|
160
|
213
|
265
|
ROE (net income / shareholders' equity)
|
-
|
64.6%
|
48.3%
|
35.7%
|
ROA (Net income/ Total Assets)
|
-
|
5.9%
|
7.56%
|
7.95%
|
Assets
1 |
-
|
3,526
|
3,689
|
4,153
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
51.5
|
58
|
62.1
|
Capex / Sales
|
-
|
1.38%
|
1.36%
|
1.32%
|
Announcement Date
|
3/13/24
|
-
|
-
|
-
|
Last Close Price
30.4
USD Average target price
32
USD Spread / Average Target +5.26% Consensus |
1st Jan change
|
Capi.
|
---|
| -.--% | 4.63B | | +25.52% | 88.99B | | -24.52% | 74.82B | | -5.56% | 25.03B | | +4.31% | 17.88B | | -14.25% | 16.43B | | +2.97% | 15.77B | | +79.20% | 13.21B | | +70.11% | 13.09B | | +40.44% | 12.9B |
Other Healthcare Facilities & Services
|